Genome, HLA and polygenic risk score analyses for prevalent and persistent cervical human papillomavirus (HPV) infections

Keyphrases

• High-risk Human Papillomavirus (HR-HPV) 100%
• Polygenic Risk Score Analysis 100%
• Cervical Human Papillomavirus Infection 100%
• HLA-DRB1 27%
• Genetic Variants 18%
• Polygenic Risk Score 18%
• Meta-analysis 9%
• Antigen Processing 9%
• Antigen Presentation 9%
• Best Model 9%
• MHC Class II Molecules 9%
• Colocalization 9%
• Study Replication 9%
• Model Fitting 9%
• Genetic Risk 9%
• Decreased Risk 9%
• Smad2 9%
• Genome-wide Association Study 9%
• Gene Set 9%
• HLA-DQB1 9%
• Weak Binding 9%
• HLA Alleles 9%
• Endocervix 9%
• HLA-DRB1 Alleles 9%
• CDH12 9%
• LDB2 9%
• Peptide Binding Prediction 9%

Biochemistry, Genetics and Molecular Biology

• HLA-DRB1 100%
• Wart Virus 100%
• Polygenic Score 100%
• Allele 50%
• Antigen Presentation 50%
• Genetic Divergence 50%
• MHC Class II 25%
• Genetic Risk 25%
• Genome-Wide Association Study 25%
• HLA-DQB1 25%

Immunology and Microbiology

• Wart Virus 100%
• HLA DRB1 Antigen 100%
• Antigen Presentation 50%
• Allele 50%
• MHC Class II 25%
• Genome-Wide Association Study 25%
• Genetic Risk 25%
• HLA DQB1 Antigen 25%